Seminars in Oncology
Volume 35, Supplement 3 , Pages S22-S27, June 2008

Potential Mechanisms of Resistance to Microtubule Inhibitors

  • Maria Kavallaris

      Affiliations

    • Children's Cancer Institute Australia for Medical Research, Randwick, NSW, Australia.
    • Corresponding Author InformationAddress correspondence to Maria Kavallaris, PhD, Children's Cancer Institute Australia for Medical Research, High Street, PO Box 81, 2031 Randwick, NSW, Australia.
  • ,
  • Jean-Philippe Annereau

      Affiliations

    • Centre de Recherche Oncologie Expérimentale, Institut de Recherche Pierre Fabre, Toulouse, France.
  • ,
  • Jean-Marc Barret

      Affiliations

    • Centre de Recherche Oncologie Expérimentale, Institut de Recherche Pierre Fabre, Toulouse, France.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital. M.K. is supported by grants and a Career Development Award from the National Health and Medical Research Council (NHMRC).Dr Kavallaris has no conflict of interest to declare. Drs Annereau and Barret are both employees of the Institut de Recherche Pierre Fabre, a private pharmaceutical company supporting the development of vinflunine.

PII: S0093-7754(08)00019-5

doi:10.1053/j.seminoncol.2008.01.006

Seminars in Oncology
Volume 35, Supplement 3 , Pages S22-S27, June 2008